| Submission declined on 27 November 2023 by Ratnahastin (talk). This submission is not adequately supported by reliable sources. Reliable sources are required so that information can be verified. If you need help with referencing, please see Referencing for beginners and Citing sources. This submission's references do not show that the subject qualifies for a Wikipedia article—that is, they do not show significant coverage (not just passing mentions) about the subject in published, reliable, secondary sources that are independent of the subject (see the guidelines on the notability of people). Before any resubmission, additional references meeting these criteria should be added (see technical help and learn about mistakes to avoid when addressing this issue). If no additional references exist, the subject is not suitable for Wikipedia.
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
|  |
John C. Jacobs | |
|---|---|
| Education | SUNY Plattsburgh Binghamton University |
| Occupation | Businessman |
| Title | CEO and President, Novavax |
John C. Jacobs is an American pharmaceutical executive.[1] He is currently the CEO and president of Novavax,[2]where he also serves as a member of the Board of Directors.[1][2]
Early life and education edit
Jacobs graduated with a B.S. in Business from SUNY Plattsburgh, and an MBA from Binghamton University.[3]
Career edit
Before joining Novavax, Jacobs worked for Cephalon, Wyeth, and Pfizer.[4][5] From 2014 to 2017, Jacobs held various executive positions at Teva Pharmaceuticals.[6][7]In October 2017, he joined Harmony Biosciences as Executive Vice President and Chief Commercial Officer. In June 2018, he was named President and CEO, and was named to the board of directors.[8][9][10]
On January 23, 2023, Jacobs succeeded Stanley Erck as President and CEO of Novavax, also joining the company’s Board of Directors.[11][12]
References edit
- ^ a b "Employment Agreement between the Company and John C. Jacobs, | NOVAVAX INC | Business Contracts | Justia". contracts.justia.com. Retrieved 2023-11-21.
- ^ a b Monica, Paul R. La (2023-03-01). "Covid vaccine maker Novavax says it may not survive | CNN Business". CNN. Retrieved 2023-11-21.
- ^ biopharma-reporter.com (2023-01-23). "Hired and retired: New appointments in the biopharma industry". biopharma-reporter.com. Retrieved 2023-11-25.
- ^ Armstrong, Annalee (9 January 2023). "Novavax CEO Stanley Erck retires after overseeing COVID shot launch". Fierce Biotech. Retrieved 24 November 2023.
- ^ DiStefano, Joseph N. (2020-10-02). "Immunome IPO on target as investors bet big on gene, cell therapies". The Philadelphia Inquirer. Retrieved 2023-11-27.
- ^ "This U.S. COVID-19 vaccine maker faces uncertain future". Deseret News. 2023-03-01. Retrieved 2023-11-21.
- ^ Bayer, Max; Mason, Gabrielle (13 January 2023). "Chutes & Ladders - Novavax CEO Stanley Erck bids adieu after 12 years, overseeing COVID vax development". Fierce Biotech. Retrieved 20 November 2023.
- ^ Gilgore, Sarah (18 January 2023). "Analysts spell out what new Novavax CEO John Jacobs could mean for the Gaithersburg biotech, its Covid vaccine". Washington Business Journal. Retrieved 27 November 2023.
- ^ George, John (26 December 2022). "2022 in Review: After two years of IPOs, the region's publicly traded life sciences firms hit tough times". Philadelphia Business Journal. Retrieved 27 November 2023.
- ^ "US agrees to buy more doses of Novavax's COVID shot". BioPharma Dive. Retrieved 2023-11-27.
- ^ Foley, Katherine Ellen; Lim, David; Gardner, Lauren (2023-01-10). "Will cost keep new Alzheimer's drug from patients?". POLITICO. Retrieved 2023-11-27.
- ^ "John Jacobs hops from Harmony to head up Novavax". www.thepharmaletter.com. Retrieved 2023-11-27.